[DPHARMA] YoY Annualized Quarter Result on 30-Jun-2024 [#2]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
15-Aug-2024
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2024
Quarter
30-Jun-2024 [#2]
Profit Trend
QoQ- 4.62%
YoY- -9.12%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 822,584 735,982 735,366 643,786 604,088 591,704 514,500 8.12%
PBT 84,122 89,610 96,238 86,746 74,236 74,204 52,340 8.22%
Tax -20,190 -19,266 -23,034 -20,738 -17,656 -17,442 -10,368 11.73%
NP 63,932 70,344 73,204 66,008 56,580 56,762 41,972 7.25%
-
NP to SH 63,932 70,344 73,204 66,008 56,580 56,762 41,972 7.25%
-
Tax Rate 24.00% 21.50% 23.93% 23.91% 23.78% 23.51% 19.81% -
Total Cost 758,652 665,638 662,162 577,778 547,508 534,942 472,528 8.20%
-
Net Worth 692,598 670,448 634,375 614,350 581,725 503,029 209,983 21.98%
Dividend
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Div 19,238 9,577 9,468 7,061 6,843 13,237 8,399 14.79%
Div Payout % 30.09% 13.62% 12.93% 10.70% 12.10% 23.32% 20.01% -
Equity
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Net Worth 692,598 670,448 634,375 614,350 581,725 503,029 209,983 21.98%
NOSH 961,942 961,942 952,239 706,330 684,383 661,881 650,902 6.72%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin 7.77% 9.56% 9.95% 10.25% 9.37% 9.59% 8.16% -
ROE 9.23% 10.49% 11.54% 10.74% 9.73% 11.28% 19.99% -
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
RPS 85.51 76.84 77.67 91.17 88.27 89.40 183.76 -11.96%
EPS 6.64 7.36 7.76 9.34 8.26 8.52 6.44 0.51%
DPS 2.00 1.00 1.00 1.00 1.00 2.00 3.00 -6.52%
NAPS 0.72 0.70 0.67 0.87 0.85 0.76 0.75 -0.67%
Adjusted Per Share Value based on latest NOSH - 961,942
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
RPS 85.51 76.51 76.45 66.93 62.80 61.51 53.49 8.12%
EPS 6.64 7.31 7.61 6.86 5.88 5.90 4.36 7.25%
DPS 2.00 1.00 0.98 0.73 0.71 1.38 0.87 14.86%
NAPS 0.72 0.697 0.6595 0.6387 0.6047 0.5229 0.2183 21.98%
Price Multiplier on Financial Quarter End Date
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Date 28/06/24 30/06/23 30/06/22 30/06/21 30/06/20 28/06/19 29/06/18 -
Price 1.26 1.30 1.20 3.03 1.62 1.37 1.30 -
P/RPS 1.47 1.69 1.55 3.32 1.84 1.53 0.71 12.88%
P/EPS 18.96 17.70 15.52 32.41 19.60 15.98 8.67 13.91%
EY 5.27 5.65 6.44 3.09 5.10 6.26 11.53 -12.22%
DY 1.59 0.77 0.83 0.33 0.62 1.46 2.31 -6.03%
P/NAPS 1.75 1.86 1.79 3.48 1.91 1.80 1.73 0.19%
Price Multiplier on Announcement Date
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Date 15/08/24 24/08/23 16/08/22 17/08/21 13/08/20 30/08/19 26/11/18 -
Price 1.17 1.19 1.34 2.49 3.15 1.41 1.08 -
P/RPS 1.37 1.55 1.73 2.73 3.57 1.58 0.59 15.05%
P/EPS 17.60 16.20 17.33 26.64 38.10 16.44 7.20 16.04%
EY 5.68 6.17 5.77 3.75 2.62 6.08 13.88 -13.82%
DY 1.71 0.84 0.75 0.40 0.32 1.42 2.78 -7.77%
P/NAPS 1.62 1.70 2.00 2.86 3.71 1.86 1.44 1.98%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment